⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
globenewswire.com
EYPT
REGN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
globenewswire.com
REGN
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of September 14, 2026 in Regeneron Pharmaceuticals, Inc. Lawsuit - REGN
globenewswire.com
REGN
Portnoy Law Firm Announces Class Action on Behalf of Regeneron Pharmaceuticals, Inc. Investors
globenewswire.com
REGN
State of the Life Sciences Industry to Be Reviewed in BCC Research's 2026 Second Quarter Outlook, Spotlighting AI-Driven Discovery, Precision Oncology, and Connected Health Adoption
globenewswire.com
TEVA
AZN
GSK
NVS
PFE
JNJ
BMY
MRK
LLY
REGN
ILMN
CHTR
EVO
AMGN
ABT
GH
Shareholders of Regeneron Pharmaceuticals, Inc. (REGN): Protect Your Rights Before September 14, 2026 - Contact Levi & Korsinsky
accessnewswire.com
REGN
REGN LAWSUIT ALERT: Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. Investors - Lead Plaintiff Deadline September 14, 2026
accessnewswire.com
REGN
September 14, 2026 Deadline Approaching: Join Class Action Against Regeneron Pharmaceuticals, Inc. (REGN) - Contact Levi & Korsinsky
accessnewswire.com
REGN
Class Action Lawsuit Filed: Regeneron Pharmaceuticals, Inc. (REGN) - Join by September 14, 2026 - Contact Levi & Korsinsky
accessnewswire.com
REGN
Veeva Vault CRM Selected by Regeneron
prnewswire.com
VEEV
REGN